Pyrimidine compounds
AssigneeAstraZeneca AB
InventorsElizabeth Janet Pease, Gloria Anne Breault, Jeffrey James Morris
Life of this patent
Estimating the term…
Loading patent…
AssigneeAstraZeneca AB
InventorsElizabeth Janet Pease, Gloria Anne Breault, Jeffrey James Morris
Estimating the term…
Pyrimidine derivatives of formula (I) wherein: Q1 and Q2 are independently selected from aryl or carbon linked heteroaryl optionally substituted as defined within; and one of Q1 and Q2 or both Q1 and Q2 is substituted on a ring carbon by one group selected from sulphamoyl, N—(C1-4alkyl)sulphamoyl (optionally substituted by halo or hydroxy), N,N-di-(C1-4alkyl)sulphamoyl (optionally substituted by halo or hydroxy), C1-4alkylsulphonyl (optionally substituted by halo or hydroxy) or a substituent of the formula (Ia) or (Ia′): wherein Q1, Q2, G, R1, Y, Z, Q3, n and m are as defined within; and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine/threonine kinase (CDK) inhibitors are also described.
A pyrimidine derivative of the formula (I):
Dependencies are inferred from the claim text.